1. Symptomatic impact and anxiety generated by performing pulmonary function tests: Are there differences between patients with fibrotic interstitial lung disease and obstructive airway disease?
- Author
-
Cascais Costa, Catarina, Mendes, Diana, Santos, Joana, Afreixo, Vera, and Gonçalo Ferreira, Pedro
- Subjects
- *
INTERSTITIAL lung diseases , *PULMONARY function tests , *OBSTRUCTIVE lung diseases , *RESPIRATORY diseases , *AIRWAY (Anatomy) , *ANXIETY - Abstract
INTRODUCTION Pulmonary function tests (PFTs) are a basic tool in the evaluation of respiratory pathology. Understanding how the underlying pathology affects its performance and the levels of dyspnea and anxiety generated in patients remain poorly studied. The aim of this study is to compare PFT performance and dyspnea levels between a group of patients with fibrotic interstitial lung disease (ILD) and a group of patients with obstructive pulmonary disease. METHODS This was a prospective study conducted between May 2021 and September 2022, with patients who underwent PFT in a level two hospital in Portugal. A questionnaire assessing vital parameters, and dyspnea and anxiety scales was applied. Data obtained before and after performing the tests were compared and analyzed. RESULTS In all, 80 patients were evaluated, 40 with some form of fibrotic ILD and 40 with obstructive airway disease. A trend towards greater elevation of cardio-respiratory stress, specially through respiratory rate, was found after PFT in the group of patients with ILD. In contrast, a trend towards higher levels of anxiety immediately before PFT was observed in patients with obstructive disease (mostly COPD) compared to that seen in the group of patients with fibrotic ILD. The variables contributing the most to length of stay in the lung function laboratory were: undergoing a bronchodilation test; the number of attempts needed to reach a technically adequate flow-volume curve; the previous degree of dyspnea, heart rate and respiratory rate before the test; and male gender. A diagnosis of fibrotic ILD was also, by itself, a determining factor for a longer stay in the lab. CONCLUSIONS There are differences in the levels of cardio-respiratory stress, anxiety, and length of stay in the lab to complete PFT between patients with ILD and obstructive airway disease. The awareness for these differences can help to anticipate hazards and allow differentiated approaches to these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF